News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
XOMA Ltd. Chief Financial Officer David Boyle II Resigns to Join Another Biotech Firm
July 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BOSTON, Jul 28, 2008 (Thomson Financial via COMTEX) -- XOMA Ltd. Monday said David Boyle II, vice president of finance and chief financial officer, has resigned from the company to join another biotechnology company.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
April 29, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Biohaven Grabs a Foothold With $600M Windfall From Oberland Capital
April 29, 2025
·
2 min read
·
Tristan Manalac
Earnings
Regeneron Shares Tumble as Eylea Declines Make for a ‘Messy Quarter’ To Come
April 29, 2025
·
1 min read
·
Annalee Armstrong
Earnings
Pfizer Announces Another $1.7B in Cost Savings, Including R&D Revamp
April 29, 2025
·
2 min read
·
Annalee Armstrong
